Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06686914 · ClinicalTrials.gov registry record · Phase 1
The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex
A Phase 1 study of Driving Performance and Cannabidiol Effects, sponsored by West Virginia University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06686914 is a Phase 1 study of Driving Performance and Cannabidiol Effects that is actively recruiting participants, run by West Virginia University. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06686914, a Phase 1 study of Driving Performance and Cannabidiol Effects, is actively recruiting participants, sponsored by West Virginia University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives/purpose of this study are to comprehensively investigate the effects of non-prescription CBD on driving performance, drowsiness, sedation, and cognitive function in a large sample of healthy adults aged 18-30 years, with additional characterization of effects by dose and by sex, using a rigorous RCT design which will naturally mitigate confounding factors.
Conditions Studied
Interventions
- DRUG Cannabidiol (CBD) Oil 300mg
- DRUG Cannabidiol (CBD) Oil 150mg
- DRUG Placebo Oil
Study Locations (1)
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2029-05-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06686914
The ClinicalTrials.gov registry entry for NCT06686914 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Driving Performance appearing as the primary indexed condition, and to 3 interventions - of which Cannabidiol (CBD) Oil 300mg is the first listed.
NCT06686914 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.
Frequently Asked Questions
What is clinical trial NCT06686914 about?
NCT06686914 is a clinical study titled "The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex". The objectives/purpose of this study are to comprehensively investigate the effects of non-prescription CBD on driving performance, drowsiness, sedation, and cognitive function in a large sample of healthy adults aged 18-30 years, with additional characterization of effects by dose and by sex, using...
What is the current status of trial NCT06686914?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 300 participants. The study started on 2025-06-30. Estimated completion is 2029-05-01.
What conditions does trial NCT06686914 study?
This clinical trial studies the following conditions: Driving Performance, Cannabidiol Effects.
What interventions are being tested in trial NCT06686914?
The interventions under investigation include: Cannabidiol (CBD) Oil 300mg (DRUG), Cannabidiol (CBD) Oil 150mg (DRUG), Placebo Oil (DRUG).
Who is sponsoring clinical trial NCT06686914?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06686914 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Driving Performance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.